Meeting the Challenge
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate:
- Acute Bacterial Exacerbations of Chronic Bronchitis due to Haemophilus influenzae (including ß-lactamase-producing strains), Moraxella catarrhalis (including ß-lactamase- producing strains), or Streptococcus pneumoniae (penicillin-susceptible strains only).
- Acute Bacterial Otitis Media due to Haemophilus influenzae (including ß-lactamase- producing strains), Moraxella catarrhalis (including ß-lactamase-producing strains), or Streptococcus pyogenes.
- Pharyngitis and Tonsillitis due to Streptococcus pyogenes.
Available in: Oral Suspension (90 mg/5 mL) and (180 mg/5 mL) and Capsules (400 mg)
|65224-800-22||Cedax® 400 mg Capsules|
|65224-804-02||Cedax® Oral Suspension 60 ml 180 mg/ 5ml|
Pernix orders are accepted via EDI transmission or by fax to 832-934-1857.
For use only under the supervision of a licensed health care provider.